A Single Dose Study Of PF-05161704 In Healthy Volunteers

NCT01183715 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: PF-05161704 or placebo
DRUG: PF-05161704 or placebo

Sponsor

Pfizer